MARATTO

article · ecancermedicalscience

Biochemical outcome in metastatic prostate cancer patients following prostate-directed radiotherapy

2024Open accessSuez Canal University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

This trial is registered on (27/4/2023), retrospectively registered with pactr.samrc.ac.za, PACTR202305854600529, URL: https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=25510.

Research topics

  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher siteRecord on OpenAlex

DOI: 10.3332/ecancer.2024.1686

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

Sign in to join the discussion

New to MARATTO™? Create a free account.